Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

Author:

Hillmen Peter1,Muus Petra2,Röth Alexander3,Elebute Modupe O.4,Risitano Antonio M.5,Schrezenmeier Hubert6,Szer Jeffrey7,Browne Paul8,Maciejewski Jaroslaw P.9,Schubert Jörg10,Urbano‐Ispizua Alvaro11,Castro Carlos12,Socié Gérard13,Brodsky Robert A.14

Affiliation:

1. St James's University Hospital Leeds UK

2. Radboud University Nijmegen Medical Centre Nijmegen The Netherlands

3. University of Duisburg‐Essen Essen Germany

4. Department of Haematological Medicine King's College Hospital London UK

5. Federico II University Naples Italy

6. Institute of Clinical Transfusion Medicine and Immunogenetics German Red Cross Blood Transfusion Service and Institute of Transfusion Medicine University of Ulm Ulm Germany

7. Royal Melbourne Hospital Melbourne Australia

8. St. James's Hospital Trinity College Dublin Dublin Ireland

9. Taussig Cancer Center Cleveland Clinic Cleveland OH USA

10. Saarland University Medical School Homburg‐Saarland Germany

11. Grupo de Trabajo de HPN de la Sociedad Española de Hematología y Hemoterapia Barcelona Spain

12. Duke University Medical Center Durham NC USA

13. Hôpital Saint‐Louis and Institut National de la Santé et de la Recherche Médicale (INSERM) Paris France

14. Johns Hopkins University School of Medicine Baltimore MD USA

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3